When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AZNCF - Amarin's Upgrade And Other News: The Good Bad And Ugly Of Biopharma
AstraZeneca Plc
Amarin Looks Promising Ahead of Full Year Results, Receives Upgrade
Amarin (AMRN) received a boost when Citigroup upgraded its stock to Buy. The target price for the stock has been set at $24 a share, showing considerable upside from the current market price, but still below its recent highs of $26 post-approval. The report stated, “We still believe Vascepa sales will accelerate strongly over the next couple years. With AMRN trading ~27% lower since November, we see now as an attractive time to buy. Also, we believe AMRN will likely emerge from